[Rituximab in the treatment of diffuse large B-cell lymphoma: The CACNA1C subunit of channel Cav1.2 expression linked to certain forms of resistance].

Autor: Bouabdallah S; M1 Biologie Santé, Université Paris-Saclay, 91405 Orsay, France., Mariko ML; M1 Biologie Santé, Université Paris-Saclay, 91405 Orsay, France., Besson J; M1 Biologie Santé, Université Paris-Saclay, 91405 Orsay, France., Dellis O; Inserm U1193 Physiopathologie et traitement des maladies du foie, Université Paris-Saclay, France.
Jazyk: francouzština
Zdroj: Medecine sciences : M/S [Med Sci (Paris)] 2021 Apr; Vol. 37 (4), pp. 406-408. Date of Electronic Publication: 2021 Apr 28.
DOI: 10.1051/medsci/2021043
Databáze: MEDLINE